State KY
Clinical Trials in Kentucky
Recruiting clinical trials with at least one study location in Kentucky. Data updated daily from ClinicalTrials.gov.
Top Conditions in Kentucky
NCT02227251 Phase 2
Recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Ly...
Condition
Diffuse Large B-cell Lymphoma
Enrollment
244 pts
Location
United States, Australia, Austria
Sponsor
Karyopharm Therapeutics Inc
NCT05948566 Phase 2
Recruiting
Strategy for Improving Stroke Treatment Response
Condition
Ischemic Stroke
Enrollment
300 pts
Location
United States
Sponsor
Translational Sciences, Inc.
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT03988439 Phase 4
Recruiting
A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants ...
Condition
Psoriasis
Enrollment
45 pts
Location
United States, Dominican Republic, Panama
Sponsor
Bausch Health Americas, Inc.
NCT06852222 Phase 3
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants ...
Condition
Leukemia, Myeloid, Acute
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT05464251 N/A
Recruiting
Prospective Analysis of Spinal Epidural Abscess
Condition
Spinal Epidural Abscess
Enrollment
200 pts
Location
United States
Sponsor
Francis Farhadi
NCT04524871 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treat...
Condition
Advanced Liver Cancers
Enrollment
518 pts
Location
United States, China, France
Sponsor
Hoffmann-La Roche
NCT02679144 Phase 2
Recruiting
Neuroblastoma Maintenance Therapy Trial
Condition
Neuroblastoma
Enrollment
441 pts
Location
United States, Canada
Sponsor
Giselle Sholler
NCT06145035 Phase 2
Recruiting
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrO...
Condition
Ischemic Heart Disease
Enrollment
60 pts
Location
United States
Sponsor
Roberto Bolli
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06547489 Phase 2
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disord...
Condition
Major Depressive Disorder
Enrollment
164 pts
Location
United States
Sponsor
Syndeio Biosciences, Inc
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
NCT04485013 Phase 1
Recruiting
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Condition
Cancer
Enrollment
240 pts
Location
United States
Sponsor
Tizona Therapeutics, Inc
NCT03747458 Phase 3
Recruiting
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Condition
Bilateral Nasal Polyposis
Enrollment
72 pts
Location
United States, Argentina
Sponsor
Optinose US Inc.
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
NCT06696014 N/A
Recruiting
Mirikizumab Real World Protocol
Condition
Ulcerative Colitis
Enrollment
100 pts
Location
United States, Canada
Sponsor
University of North Carolina,
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care i...
Condition
DLBCL
Enrollment
290 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06967389 N/A
Recruiting
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
Condition
Obesity and Overweight
Enrollment
50 pts
Location
United States
Sponsor
John Bauer
NCT05246579 N/A
Recruiting
Prospective Evaluation of Pathways for Preterm Birth
Condition
Preterm Birth
Enrollment
240 pts
Location
United States
Sponsor
John O'Brien, MD
NCT07166406 Phase 3
Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Pat...
Condition
Advanced Hepatocellular Carcinoma
Enrollment
252 pts
Location
United States
Sponsor
NRG Oncology
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Condition
Hidradenitis Suppurativa (HS)
Enrollment
225 pts
Location
United States, Canada, Germany
Sponsor
Zura Bio Inc
NCT07216482 Phase 3
Recruiting
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-03...
Condition
Hyperlipidemia
Enrollment
975 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04811560 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Condition
Acute Leukemias
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT06601218 Phase 1
Recruiting
Impact of Daily Oral Cannabis Doses in Patients With Cancer
Condition
Cancer
Enrollment
80 pts
Location
United States
Sponsor
Shanna Babalonis, PhD
NCT06339008 Phase 3
Recruiting
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (...
Condition
Perennial Allergic Rhinitis (PAR)
Enrollment
450 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company